USP aspires to be a diverse, inclusive, innovative, and engaging organization that empowers and engages staff and volunteers.
USP has been building trust in medicine for over 200 years.
The goal of the PQM+ Program is to sustainably strengthen medical product quality assurance systems in low and middle-income countries.
The Toolkit is a resource that addresses areas of vulnerability in the medical product supply chain through prevention, detection, and response strategies and actions.
Addressing barriers to the development of complex generics: Understanding challenges and opportunities.
USP comments to FDA on Docket No. FDA-2022-N-0236 for “Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information from the Inactive Ingredient Database. Comments were submitted in 2022.